InsidersTradesSigma
Discover the detailed record of transactions filed by Barrage Khalil, Director. Director active across 1 companies, notably Protagenic Therapeutics, Inc.\new. Aggregated, 2 filings have been logged. The latest transaction was disclosed on 3 May 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Khalil Barrage is a Board Member at Protagenic Therapeutics, Inc. He contributes to the governance of the company, bringing his expertise in strategy and leadership. His role is essential for guiding strategic decisions and ensuring compliance with industry standards.